featured
Bortezomib in the Management of Relapsed Acute Promyelocytic Leukemia Treated Upfront With Arsenic Trioxide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Study Evaluating the Role of Bortezomib in the Management of Relapsed Acute Promyelocytic Leukemia Treated Upfront With Arsenic Trioxide
Cancer Med 2020 Feb 14;[EPub Ahead of Print], U Kulkarni, S Ganesan, AA Alex, H Palani, S David, N Balasundaram, A Venkatraman, M Thenmozhi, L Jeyaseelan, A Korula, A Devasia, A Abraham, NB Janet, P Balasubramanian, B George, V MathewsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.